One of the most exciting new therapies for some types of cancer is to starve the tumor to death. The strategy involves destroying or blocking the blood vessels that supply the tumors with oxygen and nutrients. Without a lifeline, unwanted growth dries up and dies.
One approach is to use drugs called angiogenesis inhibitors, which prevent the formation of new blood vessels that tumors depend on for survival. But another approach is to physically block the surrounding blood vessels so that blood can no longer flow into the tumor.
The researchers experimented with various blocking mechanisms such as blood clots, gels, balloons, glue, nanoparticles and more. However, these methods have never been completely successful because blockages can be flushed out by the blood flow itself, and the material does not always completely fill the vessel, allowing blood to flow around it.
Today, Wang Qian and some friends from Tsinghua University in Beijing came up with a different approach. These people say that filling vessels with liquid metal can clog them completely. They tested their idea on mice and rabbits to see how well it worked. (All of their experiments were approved by the university’s ethics committee.)
The team experimented with two liquid metals – pure gallium, which melts at about 29 degrees Celsius, and a gallium-indium alloy with a slightly higher melting point. Both are liquids at body temperature.
Qian and colleagues first tested the cytotoxicity of gallium and indium by growing cells in their presence and measuring the number of survivors over 48 hours. If it exceeds 75%, the substance is considered safe according to Chinese national standards.
After 48 hours, more than 75 percent of the cells in both samples remained alive, in contrast to cells grown in the presence of copper, which were almost all dead. In fact, this is in line with other studies showing that gallium and indium are relatively harmless in biomedical situations.
The team then measured the extent to which liquid gallium diffused through the vascular system by injecting it into the kidneys of pigs and recently euthanized mice. X-rays clearly show how the liquid metal spreads throughout the organs and throughout the body.
One potential problem is that the structure of vessels in tumors may differ from that in normal tissues. So the team also injected the alloy into breast cancer tumors growing on the backs of mice, showing that it can indeed fill blood vessels in tumors.
Finally, the team tested how effectively the liquid metal shuts off the blood supply to the blood vessels it fills. They did this by injecting liquid metal into a rabbit’s ear and using the other ear as a control.
The tissue around the ear began to die off about seven days after the injection, and about three weeks later, the tip of the ear took on a “dry leaf” appearance.
Qian and his colleagues are optimistic about their approach. “Liquid metals at body temperature offer promising injectable tumor therapy,” they said. (By the way, earlier this year we reported on the work of the same group on the introduction of liquid metal into the heart.)
This method allows other methods to be used as well. Liquid metal, for example, is a conductor, which increases the possibility of using electric current to heat and damage surrounding tissues. The metal can also carry drug-containing nanoparticles, which, after being deposited around the tumor, diffuse into nearby tissues. There are many possibilities.
However, these experiments also revealed some potential problems. X-rays of the rabbits they injected clearly showed clots of liquid metal penetrating the hearts and lungs of the animals.
This may be the result of injecting the metal into the veins rather than the arteries, since blood from the arteries flows into the capillaries, while blood from the veins flows out of the capillaries and throughout the body. So intravenous injections are more dangerous.
What’s more, their experiments also showed the growth of blood vessels around blocked arteries, showing how quickly the body adapts to the blockage.
Of course, it is necessary to carefully assess the risks associated with such treatment and develop strategies to reduce them. For example, the spread of liquid metal through the body can be reduced by slowing blood flow during treatment, changing the melting point of the metal to freeze it in place, squeezing the arteries and veins around tumors while the metal settles, etc.
These risks also need to be weighed against the risks associated with other methods. Most importantly, of course, researchers need to find out whether it really helps to effectively kill tumors.
This will take a lot of time, money and effort. Nevertheless, it is an interesting and innovative approach that certainly deserves further study, given the huge challenges healthcare professionals face in today’s society in dealing with the cancer epidemic.
Ref: arxiv.org/abs/1408.0989: Delivery of liquid metals as vasoembolic agents to blood vessels to starve diseased tissues or tumors.
Follow the physical blog arXiv @arxivblog on Twitter and the follow button below on Facebook.
Post time: Jun-13-2023